Affiliation:
1. Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan
Abstract
The management of malignant melanoma with pulmonary metastases is controversial and occasionally requires multimodality management, including pulmonary metastasectomy after immune checkpoint inhibitors (ICIs). However, limited data are available on these patients. We described a case series of three consecutive patients who underwent pulmonary metastasectomy after ICIs for malignant melanoma and discussed the important characteristics of these patients. After pulmonary metastasectomy, none of the patients had recurrent pulmonary metastases, although extrapulmonary metastases were developed. Our case series suggests that pulmonary metastasectomy after ICIs may control pulmonary metastases in carefully selected patients with malignant melanoma.
Reference9 articles.
1. National Comprehensive Cancer Network clinical practice guidelines in oncology. Melanoma: cutaneous version 3. 2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf (accessed 8 January 2023).
2. Japanese Dermatological Association clinical practice guideline in melanoma. Available at: http://www.skincancer.jp/guideline_melanoma_v2.pdf (accessed 10 April 2023).
3. Prognostic factors for pulmonary metastasectomy in malignant melanoma: size matters
4. The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era
5. Surgical therapy for anorectal melanoma